DK0910575T3 - Fremgangsmåde til fremstilling af peptider - Google Patents

Fremgangsmåde til fremstilling af peptider

Info

Publication number
DK0910575T3
DK0910575T3 DK97927386T DK97927386T DK0910575T3 DK 0910575 T3 DK0910575 T3 DK 0910575T3 DK 97927386 T DK97927386 T DK 97927386T DK 97927386 T DK97927386 T DK 97927386T DK 0910575 T3 DK0910575 T3 DK 0910575T3
Authority
DK
Denmark
Prior art keywords
peptide
formula
defined above
optionally
substituted
Prior art date
Application number
DK97927386T
Other languages
Danish (da)
English (en)
Inventor
Chitoshi Hatanaka
Yasuaki Abe
Mitsuhisa Yamano
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0910575T3 publication Critical patent/DK0910575T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK97927386T 1996-06-21 1997-06-19 Fremgangsmåde til fremstilling af peptider DK0910575T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16179196 1996-06-21
PCT/JP1997/002097 WO1997048726A1 (en) 1996-06-21 1997-06-19 Method for producing peptides

Publications (1)

Publication Number Publication Date
DK0910575T3 true DK0910575T3 (da) 2003-02-03

Family

ID=15741986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97927386T DK0910575T3 (da) 1996-06-21 1997-06-19 Fremgangsmåde til fremstilling af peptider

Country Status (13)

Country Link
US (1) US6211333B1 (pt)
EP (1) EP0910575B1 (pt)
KR (1) KR100459978B1 (pt)
CN (1) CN1129607C (pt)
AT (1) ATE224912T1 (pt)
AU (1) AU3189997A (pt)
CA (1) CA2257381C (pt)
DE (1) DE69715860T2 (pt)
DK (1) DK0910575T3 (pt)
ES (1) ES2184096T3 (pt)
IL (3) IL127312A0 (pt)
PT (1) PT910575E (pt)
WO (1) WO1997048726A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
ATE455106T1 (de) 1999-01-22 2010-01-15 Elan Pharm Inc Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
EP1144435B1 (en) * 1999-01-26 2006-04-12 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
WO2001002428A1 (en) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Process for the preparation of lh-rh derivatives
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
ES2444215T3 (es) * 2002-07-29 2014-02-24 Zymtech Production As Método para la producción de péptidos y aminoácidos a partir de material de origen animal que comprende proteínas
ES2336826T3 (es) * 2005-05-03 2010-04-16 Novetide, Ltd. Procedimientos para la produccion de un peptido que presenta una amida c-terminal.
BRPI0616687A2 (pt) 2005-09-29 2011-06-28 Elan Pharm Inc compostos de pirimidinil amida que inibem a adesão leucocitária mediada por vla-4
CA2624524C (en) 2005-09-29 2014-07-08 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
CA2643838A1 (en) 2006-02-27 2007-09-07 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
WO2010126914A1 (en) 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins
JP6564539B1 (ja) * 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
CN113527438A (zh) * 2021-08-30 2021-10-22 湖南三太药业有限公司 一种全液相合成丙氨瑞林的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947569A (en) * 1972-04-12 1976-03-30 American Home Products Corporation Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor
US3855198A (en) 1972-09-29 1974-12-17 American Home Prod Novel intermediates for synthesis of l-(5-oxoprolyl)-l-histidy-l-tryptophyl-l-seryl-l-tyrosyl-l-glycyl-l-leucyl-l-arginyl-l-prolyl-glycine amide
JPS49100081A (pt) 1973-01-30 1974-09-20
CA1023350A (en) 1974-01-21 1977-12-27 Manfred K. Gotz Derivatives of the lh- and fsh-releasing hormone
CH611878A5 (pt) 1974-07-04 1979-06-29 Takeda Chemical Industries Ltd
DE3163800D1 (en) 1980-02-12 1984-07-05 Takeda Chemical Industries Ltd Method for protecting guanidino group and restoring the same
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
DE68928278T2 (de) 1988-02-10 1998-03-12 Tap Pharmaceuticals Inc Lhrh-analog

Also Published As

Publication number Publication date
CA2257381C (en) 2007-08-21
US6211333B1 (en) 2001-04-03
PT910575E (pt) 2003-02-28
KR20000016798A (ko) 2000-03-25
IL163521A (en) 2007-07-04
KR100459978B1 (ko) 2005-01-15
ES2184096T3 (es) 2003-04-01
CN1129607C (zh) 2003-12-03
AU3189997A (en) 1998-01-07
EP0910575B1 (en) 2002-09-25
DE69715860T2 (de) 2003-08-07
CN1222916A (zh) 1999-07-14
WO1997048726A1 (en) 1997-12-24
CA2257381A1 (en) 1997-12-24
IL127312A0 (en) 1999-09-22
DE69715860D1 (de) 2002-10-31
ATE224912T1 (de) 2002-10-15
IL163521A0 (en) 2005-12-18
EP0910575A1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
DK0910575T3 (da) Fremgangsmåde til fremstilling af peptider
US5384410A (en) Removal of boronic acid protecting groups by transesterification
SE8403931D0 (sv) Treo-3-amino-2-hydroxi-4-oxosmorsyraderivat
Holzapfel et al. Antineoplastic agents. Par 108. Structural biochemistry. Part 23. Synthesis of the dolastatin thiazole amino acid component (gln) Thz
ES2000910A6 (es) Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos
DE69015811D1 (de) Insulinverbindungen.
ES8200645A1 (es) Un procedimiento para la preparacion de un muramildipeptido.
KR900009692A (ko) 레트로바이러스 프로테아제 억제제
AU2308695A (en) Agents and a process for waterproofing leather and furs
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
IL92660A0 (en) Enzyme-inhibiting amino acid derivatives,a process for the preparation thereof,compositions containing these,and the use thereof
US3757003A (en) Process for preparing l pyroglutamyl l histidyl l prolinamide
GB1510477A (en) Peptides and to amino acid intermediates thereof
ES453304A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoacidos.
ES435955A1 (es) Un procedimiento para obtener un derivado de pirido (3,4-d) piridezina.
SE7704088L (sv) Sett att framstella dipeptidderivat
US4087419A (en) Heptapeptides and methods for their production
US4033997A (en) Preparation of dopamine derivatives
ES8105970A1 (es) Procedimiento para preparar acidos metil aminoalcanoicos fluorados.
ATE13527T1 (de) Verfahren zur herstellung von beta-hydroxy-alpha- aminocarbonsaeuren.
ATE18206T1 (de) Verfahren zur herstellung eines laktams.
US4035348A (en) Tetrapeptides and methods for their production
ES8106695A1 (es) Un procedimiento para la pre-paracion de un peptido.
DE59602077D1 (de) Verfahren zur Herstellung von (4,5)-trans-Oxazolidin-derivaten
US4087417A (en) Hexapeptides and methods for their production